Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Insulet Corporation PODD

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to... see more

Recent & Breaking News (NDAQ:PODD)

Insulet Launches Omnipod® 5 and Omnipod Discover(TM) in the Middle East to Transform Diabetes Care

Business Wire 2 days ago

Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026 

Business Wire January 9, 2026

Insulet Redefines Diabetes at CES with "Liveable Technology" - A New Frontier in Human-Centered Connected Health

Business Wire January 6, 2026

Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference

Business Wire December 16, 2025

Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future

Business Wire December 15, 2025

Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience

Business Wire December 4, 2025

Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day

Business Wire November 20, 2025

Insulet Reports Third Quarter 2025 Results

Business Wire November 6, 2025

Insulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness Month

Business Wire October 30, 2025

Insulet Announces Appointment of Robert L. Huffines to its Board of Directors

Business Wire October 23, 2025

Insulet to Host Investor Day on November 20, 2025

Business Wire October 10, 2025

Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette

Business Wire September 18, 2025

Insulet Announces CFO Transition

Business Wire September 16, 2025

Insulet Elevates Eric Benjamin to Chief Operating Officer

Business Wire August 25, 2025

Insulet to Participate in Upcoming Investor Conferences

Business Wire August 19, 2025

Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency1)

Business Wire August 7, 2025

Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025

Business Wire July 8, 2025

Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions

Business Wire June 19, 2025

Insulet's Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users

Business Wire June 10, 2025

Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

Business Wire May 23, 2025